Literature DB >> 9853288

Augmenting solute clearance in peritoneal dialysis.

R T Krediet1, C E Douma, R W van Olden, M M Ho-dac-Pannekeet, D G Struijk.   

Abstract

BACKGROUND: The removal of low molecular weight solutes by peritoneal dialysis is less than by hemodialysis. The targets for Kt/Vurea and creatinine clearance formulated in the Dialysis Outcome Quality Initiative are unlikely to be achieved in a substantial portion of peritoneal dialysis patients. Possibilities to increase small solute clearances have therefore been subject to many investigations.
METHODS: A review of the literature and of recent new data on determinants of solute removal, such as residual renal function, the role of drained dialysate volume and manipulation of the diffusive capacity of the peritoneum are presented.
RESULTS: The contribution of residual GFR is more important for the clearance of creatinine than for Kt/Vurea. It is even more important for the removal of organic acids that are removed from the body by tubular secretion. High dosages of furosemide increase the urinary volume and the fractional Na+ excretion, but have no effect on the magnitude of residual GFR, renal creatinine clearance, renal urea clearance, and peritoneal transport characteristics. The drained dialysate volume per day is the main determinant of the peritoneal removal of urea. Its effect decreases the higher the molecular weight of a solute. It can be augmented by using large instillation volumes, by the application of more exchanges, and by increasing peritoneal ultrafiltration. A large exchange volume is especially effective in patients with an average transport state, but in those with high solute transport rates, Kt/Vurea is especially influenced by the number of exchanges. Possibilities to increase ultrafiltration are discussed. The diffusive capacity of the peritoneum can be augmented by using low dosages of intraperitoneally administered nitroprusside. This increases solute transport most markedly when it is applied in combination with icodextrin as osmotic agent.
CONCLUSIONS: Small solutes clearances cannot be increased by furosemide. Increasing the instilled volume of dialysis fluid and the number of exchanges both affect solute clearance. Studies are necessary on long-term effects of manipulation of the peritoneal membrane with nitroprusside.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9853288     DOI: 10.1046/j.1523-1755.1998.00181.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.

Authors:  Alp Akonur; Steven Guest; James A Sloand; John K Leypoldt
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

2.  Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis.

Authors:  Helton P Lemes; Salustiano Araujo; Daniella Nascimento; Danny Cunha; Cesar Garcia; Vinicius Queiroz; Sebastião R Ferreira-Filho
Journal:  Clin Exp Nephrol       Date:  2011-03-18       Impact factor: 2.801

3.  Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients.

Authors:  Jongha Park; Rajnish Mehrotra; Connie M Rhee; Miklos Z Molnar; Lilia R Lukowsky; Sapna S Patel; Allen R Nissenson; Joel D Kopple; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2013-06-05       Impact factor: 5.992

4.  Sacubitril-Valsartan Increases Ultrafiltration in Patients Undergoing Peritoneal Dialysis: A Short-Term Retrospective Self-Controlled Study.

Authors:  Fen Zhang; Tingting Zhang; Sisi Yang; Di Wang; Qianqian Zhuo; Xianhui Qin; Nirong Gong; Jun Ai
Journal:  Front Med (Lausanne)       Date:  2022-06-03

5.  Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision making.

Authors:  Krista Dybtved Kjaergaard; Jens Dam Jensen; Christian Daugaard Peters; Bente Jespersen
Journal:  NDT Plus       Date:  2011-04-04

6.  MMP-7 affects peritoneal ultrafiltration associated with elevated aquaporin-1 expression via MAPK/ERK pathway in peritoneal mesothelial cells.

Authors:  Yue Yin; Fen Zhang; Zhuojun Zheng; Zhiwen Xiao; Qiaomu Yang; Nirong Gong; Jia Zhou; Daming Zuo; Jun Ai
Journal:  J Cell Mol Med       Date:  2021-06-11       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.